Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
5.50%
↓ 92% below average
Average (39q)
72.52%
Historical baseline
Range
High:2761.06%
Low:-97.45%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 5.50% |
| Q2 2025 | 6.84% |
| Q1 2025 | -64.15% |
| Q4 2024 | 20.94% |
| Q3 2024 | 2.70% |
| Q2 2024 | 8.55% |
| Q1 2024 | -9.40% |
| Q4 2023 | -1.07% |
| Q3 2023 | 17.78% |
| Q2 2023 | -5.07% |
| Q1 2023 | -1.95% |
| Q4 2022 | -6.78% |
| Q3 2022 | 9.45% |
| Q2 2022 | -13.04% |
| Q1 2022 | -0.75% |
| Q4 2021 | 0.35% |
| Q3 2021 | -12.03% |
| Q2 2021 | 19.80% |
| Q1 2021 | 0.79% |
| Q4 2020 | -21.88% |
| Q3 2020 | -38.52% |
| Q2 2020 | -3.41% |
| Q1 2020 | 49.35% |
| Q4 2019 | 15.89% |
| Q3 2019 | 25.32% |
| Q2 2019 | -17.39% |
| Q1 2019 | -29.14% |
| Q4 2018 | 43.46% |
| Q3 2018 | -97.45% |
| Q2 2018 | 2761.06% |
| Q1 2018 | -60.18% |
| Q4 2017 | -37.57% |
| Q3 2017 | 342.13% |
| Q2 2017 | 39.88% |
| Q1 2017 | -33.97% |
| Q4 2016 | 3.07% |
| Q3 2016 | 10.89% |
| Q2 2016 | -44.35% |
| Q1 2016 | 49.56% |
| Q4 2015 | -34.33% |